Masterclass in amyloid PET for management and diagnosis of Alzheimer's disease

The University of Melbourne and National Imaging Facility hosted a workshop on the theory and practice of PET imaging modalities in the clinical care of Alzheimer’s Disease. This event is sponsored by Lilly, and hosted by National Imaging Facility, University of Melbourne, Australian Dementia Network, The Florey and Austin Health. ---------------------------------- SPEAKERS: Prof. Christopher Rowe is a neurologist and nuclear medicine specialist at Austin Health and a Professor of the University of Melbourne. He has been the imaging leader of the AIBL study since 2006 and is the Director of the Australian Dementia Network (ADNeT), a national collaboration of 19 universities and research institutes. His research focus is PET brain imaging and blood biomarkers for Alzheimer’s disease, to advance understanding of the disease, translate recent advancements in diagnostics into clinical practice, and to facilitate prevention and treatment trials. He has over 450 publications and is a Highly Cited researcher, in the top 1% world-wide for neuroscience. Mr Rob Williams is Facility Fellow of the National Imaging Facility at the University of Melbourne’s Melbourne Brain Centre Imaging Unit. Rob’s research interests include Amyloid and Tau quantification, and new harmonisation approaches for improved PET quantification in multi-site clinical trials. Dr Katie Davey is an Informatics Fellow in the National Imaging Facility and Senior Lecturer at the University of Melbourne, conducting research into enhancing the acquisition and analyses of neuroimaging data, with a special interest in signal processing and AI. More information about the University of Melbourne Brain Centre Imaging Unit: medicine.unimelb.edu.au/school-structure/radiology/news-and-events/mbciu More information about the National Imaging Facility: anif.org.au